Rebecca Dabora
Hoofd Techniek/Wetenschap/O&O bij APOGEE THERAPEUTICS, INC.
Oorsprong van het eerstegraads netwerk van Rebecca Dabora
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 27 | |
| Public Company | Biotechnology | 19 | |
SwanBio Therapeutics, Inc.
 SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA.
4
| Holding Company | Biotechnology | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Rebecca Dabora via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal General Counsel | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Public Communications Contact Corporate Officer/Principal | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Sales & Marketing Chief Tech/Sci/R&D Officer | |
Venrock Associates
 Venrock Associates Investment ManagersFinance Venrock Associates is an Independent Venture Capital firm founded in 1969. The firm is headquartered in Palo Alto. | Investment Managers | Private Equity Investor Private Equity Investor | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director of Finance/CFO General Counsel | |
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Chief Administrative Officer | |
Adimab LLC
 Adimab LLC BiotechnologyHealth Technology Adimab LLC provides human therapeutic antibodies. The firm has discovered antibodies for a wide variety of therapeutic targets within many disease areas, including oncology, immunomodulation, inflammation, neuroscience and pain, cardiovascular and metabolic disease and infectious disease. The company was founded in 2007 by Tillman Gerngross, Dane Wittrup and Errik Anderson and is headquartered in Lebanon, NH. | Biotechnology | Director/Board Member Chairman Director/Board Member Director/Board Member Corporate Officer/Principal | |
AppDirect, Inc.
 AppDirect, Inc. Packaged SoftwareTechnology Services AppDirect, Inc. develops end-to-end commerce platform for selling, distributing, and managing cloud-based products and services. It offers AppMarket, AppReseller, AppBilling, and AppDistribution. The company was founded by Nicolas Desmarais, Andy Sen, and Daniel H. Saks in 2009 and is headquartered in San Francisco, CA. | Packaged Software | Director/Board Member | |
| SPYRE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Flex Logix Technologies, Inc.
 Flex Logix Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Flex Logix Technologies, Inc. provides software services. Its products include embedded FPGA, SOC applications and EFLX compiler. The company was founded by Cheng Wang, Fang-Li Yuan and Geoffrey Tate in March 2014 and is headquartered in Mountain View, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Helion Energy, Inc.
 Helion Energy, Inc. Industrial MachineryProducer Manufacturing Helion Energy, Inc. manufactures power generation technology. It develops power plants that would produce electricity by running a nuclear-fusion reaction whereby atoms merge at extremely high temperatures. The company was founded by David Kirtley, John Slough, Chris Pihl and George Votroubek in 2009 and is headquartered in Redmond, WA. | Industrial Machinery | Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Graduate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Undergraduate Degree | |
| Stanford University | College/University | Doctorate Degree Doctorate Degree | |
| University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| Emory University | College/University | Graduate Degree Undergraduate Degree | |
| The Johns Hopkins University | College/University | Corporate Officer/Principal Graduate Degree | |
| Tufts University | College/University | Undergraduate Degree Graduate Degree | |
GlycoFi, Inc.
 GlycoFi, Inc. BiotechnologyHealth Technology GlycoFi, Inc. develops biopharmaceutical products. It provides protein production technology to develop, produce and commercialize biotherapeutics products. The company was founded by Tillman Gerngross in 2000 and is headquartered in Lebanon, NH. | Biotechnology | Director/Board Member Founder | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Novartis Vaccines & Diagnostics, Inc.
 Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| Canada-US Fulbright Program Foundation | Director/Board Member | ||
| FRACTYL HEALTH, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Avitide, Inc.
 Avitide, Inc. BiotechnologyHealth Technology Avitide, Inc. develops affinity purification solutions. Its technology enables development of chromatography resins via chemical synthesis which are not based on costly recombinant proteins. The company was founded by Errik B. Anderson, Warren Kett, Tillman U. Gerngross, Kevin Isett and Jonathan Sheller in 2012 and is headquartered in Lebanon, NH. | Biotechnology | Founder Director/Board Member | |
| ALECTOR, INC. | Biotechnology | Director/Board Member Founder | |
| Harvard Business School | College/University | Masters Business Admin Corporate Officer/Principal Masters Business Admin Masters Business Admin | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
| XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Oklo, Inc.
 Oklo, Inc. Miscellaneous Commercial ServicesCommercial Services Oklo, Inc. constructs reactor and distributes power. The company was founded by Jacob DeWitte and Caroline Cochran and is headquartered in Mountain View, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| PROMETHEUS BIOSCIENCES, INC. | Biotechnology | Investor Relations Contact Chief Executive Officer | |
| BRIDGEBIO PHARMA, INC. | Biotechnology | Corporate Officer/Principal Human Resources Officer Corporate Officer/Principal | |
| AKERO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Population Health Partners LLC
 Population Health Partners LLC Investment ManagersFinance Population Health Partners LLC (Population Health Partners) is a private equity/venture capital founded in 2020 by Whit Bernard, Tamsin Berry, Chris Cox and Clive Meanwell. The firm is headquartered in San Francisco, California with an additional office in London. | Investment Managers | Founder Founder | |
| X4 PHARMACEUTICALS, INC. | Biotechnology | Chairman Chief Executive Officer | |
Ankyra Therapeutics, Inc.
 Ankyra Therapeutics, Inc. Medical/Nursing ServicesHealth Services Ankyra Therapeutics, Inc. engages in the provision of healthcare services. The company is headquartered in Boston, MA. | Medical/Nursing Services | Founder Director/Board Member | |
| ENTASIS THERAPEUTICS HOLDINGS INC. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
| Life Science Cares, Inc. | Director/Board Member Director/Board Member | ||
| CARGO THERAPEUTICS, INC. | Biotechnology | Director/Board Member General Counsel | |
Origin Biosciences, Inc.
 Origin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., Origin Biosciences, Inc. is an actively managed investment issuer focused on making equity investments in psychedelics industry-related companies to provide investors with diverse exposure to the sector. The company is based in Palo Alto, CA. The company, led by a team of industry experts, leverages its management expertise, professional network, and due diligence process to identify and invest in leading and emerging companies focused on the emerging psychedelics sector. Michael Henderson has been the CEO of the company since 2018. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
QED Therapeutics, Inc.
 QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., QED Therapeutics, Inc. is a biotechnology company based in Palo Alto, CA. The company focuses on precision medicine for FGFR-driven diseases and is committed to finding solutions to FGFR-driven cancers and diseases to give patients more possibilities. QED Therapeutics' lead investigational candidate is infigratinib, an orally administered, FGFR1-3 selective tyrosine kinase inhibitor that has shown activity in patients with chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions and advanced urothelial carcinoma with FGFR3 genomic alterations. In 2020, QED submitted a new drug application (NDA) with the Food and Drug Administration for second- and later-line cholangiocarcinoma. Michael Henderson has been the CEO of the company since 2017. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer |
Statistieken
Internationaal
| Verenigde Staten | 48 |
| Canada | 2 |
Sectoraal
| Health Technology | 29 |
| Consumer Services | 11 |
| Commercial Services | 4 |
| Finance | 3 |
| Technology Services | 2 |
Operationeel
| Director/Board Member | 234 |
| Corporate Officer/Principal | 99 |
| Independent Dir/Board Member | 77 |
| Undergraduate Degree | 46 |
| Chief Executive Officer | 37 |
Sterkste connecties
| Insiders | |
|---|---|
| Terry McGuire | 54 |
| Ellen Marram | 33 |
| Michael Wyzga | 31 |
| Jane Henderson | 25 |
| Ajay Royan | 24 |
| Fred Driscoll | 21 |
| Clive Meanwell | 21 |
| Tomas Jan Heyman | 18 |
| Halley Gilbert | 17 |
| Thomas Anderson | 17 |
| Howard Mayer | 16 |
| William Jones | 14 |
| Michael Henderson | 14 |
| Patrick C. Hutchison | 14 |
| Jennifer Fox | 13 |
- Beurs
- Insiders
- Rebecca Dabora
- Bedrijfsconnecties
